Predicting differentiation potential of human pluripotent stem cells: Possibilities and challenges

Area of Science:

• Stem cell biology
• Regenerative medicine

Background:

• Human pluripotent stem cells (hPSCs) offer immense potential for research and clinical applications due to their self-renewal and differentiation capabilities.
• Variability in hPSC pluripotency and differentiation necessitates rigorous screening for specific applications to ensure efficiency and cost-effectiveness.
• Traditional methods like teratoma formation and gene expression profiling are used to assess hPSC quality, but have limitations.

Discussion:

• RNA sequencing provides a quantitative in vivo assessment of hPSC differentiation potential, complementing teratoma assays.
• Gene expression-based scorecards can predict differentiation capacity into specific lineages prior to terminal differentiation.
• Evaluating malignant potential is critical for clinical translation, combining histology and gene expression analysis of teratomas.

Key Insights:

• Current methods for hPSC characterization are often time-consuming, labor-intensive, and costly.
• Discordance between different assays limits the reliability and routine application of existing prediction methods.
• There is a pressing need for simpler, rapid, and highly sensitive assays to monitor hPSC status and predict differentiation potential.

Outlook:

• Development of faster, more specific assays for hPSC quality control is essential for routine research and clinical translation.
• Identifying fewer, more targeted markers could streamline the prediction of differentiation into desired cell types.
• Future advancements aim to overcome current limitations, enabling wider and more efficient use of hPSCs.